StockData
Vycor Medical Inc logo

Vycor Medical Inc (VYCO) stock

VYCOOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$0.07+0.00 (0.00%)

Close on Oct 19, 2026Market cap $2.24MP/E –Yield –

How the market prices Vycor Medical

Each ratio against its own distribution since 2016, from month-end prices and the figures reported at the time

Vycor Medical trades at 1.2× its earnings, against a median of 2.5× since 2016 — cheaper than 95% of the months in between.

The shaded bar covers the 5th to 95th percentile of month-end values since 2016, the darker part the 25th to 75th, the line the median and the dot today. The figure on the right is the percentile today sits at.

Price to sales since 2016

Median 2.5×, today 1.2×

What Vycor Medical keeps of every dollar

Trailing twelve months, from revenue down to net income. Grey columns are what comes out.

Margins against the industry

Gross margin83.4%vs 55.4%
Operating margin2.67%vs -5.17%
EBITDA margin5.91%vs -2.67%
Pretax margin-3.12%vs -2.76%
Net margin-3.32%vs -10.3%

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it earns on the capital it uses

Trailing twelve months over average capital

Return on assets-7.08%vs -12.2%

How hard the assets work

Revenue per dollar of assets2.14vs 0.58
Inventory turns a year1.73vs 2.23
Revenue per employee$258.21Kvs $328.95K
Profit per employee-$8.56Kvs -$48.85K

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

What it owes and what covers it

Latest balance sheet, against twelve months of cash generation

Cash and short-term investments exceed every borrowing by $24.93K.

Total debt$133.98K
Cash and short-term investments$158.91K
EBITDA, trailing twelve months$106.84K

Leverage and liquidity

Debt to EBITDA1.25vs 2.47
Net debt to EBITDA-0.23vs 1.49
Current ratio0.13vs 2.50
Quick ratio0.07vs 1.55

The grey tick and the second figure are the median of companies in the same industry group; green means this company is on the better side of it.

Scores and rules of thumb

Academic scores computed from the latest two fiscal years. They are screens, not verdicts.

Piotroski F-Score

Nine yes-or-no tests of profit, leverage and efficiency against last year.

3 of 9 tests passed

Beneish M-Score

Eight variables that flag accounts shaped to look better than they are.

-3.00
No flagManipulation risk

How the shares have traded

Total return includes reinvested dividends, to the close on Oct 19, 2026

Total return against the S&P 500

The axis is compressed: each step is ten times the one before, so a month and a decade fit on the same line.

VYCOS&P 500
PeriodVYCOS&P 500DifferenceVYCO per yearS&P 500 per year
1 month0.0%+0.6%−0.6 pts
3 months-2.9%+3.4%−6.3 pts
Year to date-44.6%+13.3%−57.9 pts
1 year-46.0%+16.6%−62.6 pts
3 years-29.5%+86.4%−115.9 pts-11.0%+23.1%
5 years-47.7%+81.9%−129.5 pts-12.1%+12.7%
10 years-73.2%+318.9%−392.1 pts-12.3%+15.4%

Who is betting against it

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.

0M VYCO shares were sold short on Oct 15, 2026, up 0.0% from the previous report. At recent volumes it would take 1000.0 days to buy them back.

Shares sold shortDays to cover

The last twelve reports

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 15, 202612,0920.0%11000.0
Sep 30, 202612,0920.0%01000.0
Sep 15, 202612,092-36.7%26,4001.0
Aug 31, 202619,092+186.2%46,9561.0
Aug 14, 20266,6700.0%01000.0
Jul 31, 20266,6700.0%01000.0
Jul 15, 20266,670-4.2%3,0692.2
Jun 30, 20266,960-11.2%7948.8
Jun 15, 20267,836+4.6%8,3271.0
May 29, 20267,489-34.2%13,3771.0
May 15, 202611,389+0.4%1,8276.2
Apr 30, 202611,339–13,3091.0

Every measure, in full

41 figures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Share statisticsIndustry

Shares Change (YoY)
-3.49%
3.51%
Shares Change (QoQ)
0.00%
0.31%
Float
33M
38M
Shares Held by Insiders
0.00%
10.4%

MarginsIndustry

Gross Margin
83.4%
55.4%
Operating Margin
2.67%
-5.17%
Pretax Margin
-3.12%
-2.76%
Profit Margin
-3.32%
-10.3%
EBITDA Margin
5.91%
-2.67%

Returns on capitalIndustry

Return on Assets (ROA)
-7.08%
-12.2%

Financial positionIndustry

Current Ratio
0.13
2.50
Quick Ratio
0.07
1.55
Debt / EBITDA
1.25
2.47
Net Debt / EBITDA
-0.23
1.49

GrowthIndustry

Revenue Growth (YoY)
1.61%
9.06%
Revenue Growth (3Y CAGR)
15.1%
7.08%
Revenue Growth (5Y CAGR)
10.3%
11.8%

EfficiencyIndustry

Asset Turnover
2.14
0.58
Inventory Turnover
1.73
2.23
Revenue Per Employee
$258.21K
$328.95K
Profits Per Employee
-$8.56K
-$48.85K
Employee Count
7
193

Income statement (TTM)Industry

Revenue
$1.81M
$104.77M
Gross Profit
$1.51M
$61.99M
Operating Income
$48.22K
-$3.82M
Pretax Income
-$56.40K
-$2.12M
Net Income
-$59.93K
-$6.19M
EBITDA
$106.84K
-$2.02M
EPS (Diluted)
$0.00
-$0.08

Balance sheetIndustry

Total Debt
$133.98K
$99.39M
Net Cash (Debt)
$24.93K
$3.73M
Net Cash Per Share
$0.00
$0.28
Equity (Book Value)
-$4.25M
$63.83M
Book Value Per Share
-$0.13
$2.98
Tangible Book Value
-$4.25M
$10.75M
Working Capital
-$4.29M
$57.32M

Cash flow (TTM)Industry

Operating Cash Flow
$61.38K
-$463.66K

Scores and fair valueIndustry

Piotroski F-Score
3
5
Beneish M-Score
-3.00
-2.64

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?